Strong NANOG expression was found in 22 (27%) lesions and was established as cut-off point, showing the most robust association with laryngeal cancer risk (p = 0.003) superior to the histological classification (p = 0.320). The gene discussed is NANOG; the disease is laryngeal carcinoma.